Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 4INDUSTRY 3NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Astrocytoma 29Central Nervous System Neoplasms 28Unspecified Adult Solid Tumor, Protocol Specific 18Ovarian Neoplasms 17Oligodendroglioma 17Medulloblastoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Lung Neoplasms 15Optic Nerve Glioma 14Neuroblastoma 14Lymphoma 14Carcinoma, Non-Small-Cell Lung 14Leukemia 13Glioblastoma 13Familial ependymoma 12Choroid Plexus Neoplasms 12Carcinoma, Ovarian Epithelial 12Fallopian Tube Neoplasms 11Burkitt Lymphoma 11Breast Neoplasms 11Sarcoma 10Colorectal Neoplasms 9Brain Neoplasms 9Recurrence 8Lymphoma, Large B-Cell, Diffuse 8Brenner Tumor 8Lymphoma, Non-Hodgkin 7Glioma 7Colonic Neoplasms 7Uterine Cervical Neoplasms 6

Interventions

Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × NETWORK × Nausea × Clear all
NCT00930332 2024-02-12

Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain

Canadian Cancer Trials Group

Phase 1 Terminated
8 enrolled

Nausea, Pain, Sleep Wake Disorders, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡